1. 19th biennial IPEG Meeting. Issue 1 (November 2016) Authors: Timofeev, Igor; Kenemans, Leon; Fabene, P.; Ahnaou, A.; Olbrich, Sebastian; Oostenveld, Robert; Arns, Martijn; Boutros, Nash; da Silva, Fernando; Timofeev, Igor; Jensen, Ole; Loo, Sandra; Landolt, Hans-Peter; Schoffelen, Jan; Gouw, Alida; Hillebrand, Arjan; Demuru, Matteo; Ris, Peterjan; Schelten... Journal: Neuropsychiatric electrophysiology Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 19th biennial IPEG Meeting. Issue 1 (November 2016) Authors: Timofeev, Igor; Kenemans, Leon; Fabene, P.; Ahnaou, A.; Olbrich, Sebastian; Oostenveld, Robert; Arns, Martijn; Boutros, Nash; da Silva, Fernando; Timofeev, Igor; Jensen, Ole; Loo, Sandra; Landolt, Hans-Peter; Schoffelen, Jan; Gouw, Alida; Hillebrand, Arjan; Demuru, Matteo; Ris, Peterjan; Schelten... Journal: Neuropsychiatric electrophysiology Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bioavailability and pharmacokinetic profile of balovaptan, a selective, brain-penetrant vasopressin 1a receptor antagonist, in healthy volunteers. (3rd August 2021) Authors: Derks, Michael; Lennon-Chrimes, Sian; Guenther, Andreas; Squassante, Lisa; Wandel, Christoph; Szczesny, Piotr; Paehler, Axel; Kletzl, Heidemarie Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 8(2021) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical Pharmacology Knowledge, Opportunities and Working Strengths (CPKNOWS): a competency model for pursuit of excellence in clinical pharmacology. (December 2013) Authors: Nieforth, Keith A.; Abdallah, Hisham Y.; Smith, Patrick; Derks, Michael; Boutouyrie, Bruno; Sarapa, Nenad; Peck, Richard W. Journal: British journal of clinical pharmacology Issue: Volume 76:Number 6(2013:Dec.) Page Start: 841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Population Pharmacokinetic and Exposure–dizziness Modeling for a Metabotropic Glutamate Receptor Subtype 5 Negative Allosteric Modulator in Major Depressive Disorder Patients. Issue 5 (27th June 2018) Authors: Cosson, Valérie; Schaedeli‐Stark, Franziska; Arab‐Alameddine, Mona; Chavanne, Clarisse; Guerini, Elena; Derks, Michael; Mallalieu, Navita L. Journal: Clinical and translational science Issue: Volume 11:Issue 5(2018) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Results and evaluation of a first‐in‐human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods. (18th December 2017) Authors: Sturm, Stefan; Delporte, Marie‐Laure; Hadi, Salah; Schobel, Scott; Lindemann, Lothar; Weikert, Robert; Jaeschke, Georg; Derks, Michael; Palermo, Giuseppe Journal: British journal of clinical pharmacology Issue: Volume 84:Number 3(2018:Sep.) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗